The effects of parenteral fish oil on neurodevelopment in preterm infants: A narrative review

N Ikeda1, E Shepherd2, M Makrides2

  • 1Women and Kids Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan.

Insights

Parenteral fish oil supplementation for preterm infants shows mixed results. While some studies suggest potential neurodevelopmental benefits, more research is needed due to limited evidence quality.

Area of Science:

  • Neonatal Medicine
  • Neuroscience
  • Nutritional Science

Background:

  • Preterm infants are at risk for neurodevelopmental challenges.
  • Parenteral nutrition is crucial for extremely premature infants.
  • Fish oil (omega-3 fatty acids) is investigated for its role in brain development.

Purpose of the Study:

  • To review existing literature on the impact of parenteral fish oil on neurodevelopment in preterm infants.
  • To synthesize findings from randomized controlled trials and observational studies.

Main Methods:

  • A comprehensive literature search was conducted in PubMed from July 1985 to October 2023.
  • Included were randomized controlled trials and observational studies of preterm infants receiving intravenous fish oil.
  • Studies reporting long-term neurodevelopmental outcomes were prioritized.

Main Results:

  • Three randomized controlled trials and four cohort studies were identified.
  • Heterogeneity in study designs and outcomes prevented meta-analysis.
  • Trial results for neurodevelopmental outcomes were largely null; however, cohort studies suggested possible benefits of fish oil supplementation.
  • Methodological limitations impact the certainty of the evidence.

Conclusions:

  • The current evidence on parenteral fish oil's effect on preterm infant neurodevelopment is inconclusive.
  • Further high-quality research is necessary to establish definitive conclusions.
  • Optimal use of fish oil in parenteral nutrition for preterm infants requires more investigation.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...